Home » Topics » Disease categories and therapies » Musculoskeletal

Musculoskeletal
RSS

FASST study of lanifibranor in diffuse cutaneous systemic sclerosis does not meet primary endpoint

Feb. 19, 2019

Grant to support phase II development of AKL's APPA for osteoarthritis

Feb. 18, 2019

Nimbus Lakshmi discloses new TYK2 inhibitors

Feb. 14, 2019

Misplaced energy turns T cells proinflammatory

Feb. 7, 2019

Evidence of molecular mechanism of DZ-2002 on glomerulonephritis in SLE

Feb. 5, 2019

TNF levels do not predict TNF blocker success

Feb. 5, 2019

New sphingosine 1-phosphate receptor antagonists reported by Galapagos

Jan. 29, 2019

I-Mab Biopharma begins first-in-human study of TJ-003234

Jan. 28, 2019

Results from phase I/II study of rituximab biosimilar ABP-798 in rheumatoid arthritis

Jan. 25, 2019

Study more than doubles known osteoarthritis risk genes

Jan. 25, 2019

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 6, 2026.
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 31, 2026
Hematopoietic stem cell research points to leukemia’s early roots
BioWorld Science
Hematopoietic stem cell (HSC) research over the past century has shown that leukemia may be driven by an invisible hand of inflammation. The bone marrow and...
Infinimmune presents preclinical data on anti-IL-22 antibody for atopic dermatitis
BioWorld Science
Infinimmune Inc. has recently presented results at the annual American Academy of Dermatology conference regarding their anti-IL-22 antibody IFX-101 for the...